Jennifer Wellman
About
In The Last Decade
Jennifer Wellman
19 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Molecular Biology 1.1k
- Genetics 600
- Ophthalmology 400
- Cellular and Molecular Neuroscience 180
- Radiology, Nuclear Medicine and Imaging 149
Countries citing papers authored by Jennifer Wellman
This map shows the geographic impact of Jennifer Wellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Wellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Wellman more than expected).
Fields of papers citing papers by Jennifer Wellman
This network shows the impact of papers produced by Jennifer Wellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Wellman. The network helps show where Jennifer Wellman may publish in the future.
Co-authorship network of co-authors of Jennifer Wellman
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Wellman. A scholar is included among the top collaborators of Jennifer Wellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Wellman. Jennifer Wellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 149 | |
| 5 | Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy breakdown → | 276 |
| 6 | Three-year update for the phase 3 voretigene neparvovec study in biallelic RPE65 mutation–associated inherited retinal disease | 2 |
| 7 | 2 | |
| 8 | Correlation of multi-luminance mobility testing with visual function tests in a phase 3 trial of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease | 3 |
| 9 | Year 2 results for a phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease | 6 |
| 10 | Natural History of Individuals with Retinal Degeneration Due to Biallelic Mutations in the RPE65 Gene | 2 |
| 11 | 105 | |
| 12 | The Natural History of Disease Progression in Patients With RPE65-Mediated Inherited Retinal Dystrophies | 0 |
| 13 | 3 | |
| 14 | Absence of genotype-phenotype correlations in RPE65 gene mutations associated with autosomal recessive retinal dystrophy | 2 |
| 15 | Mobility testing validation study - Using a novel, standardized mobility test to evaluate functional vision in patients with inherited retinal degeneration | 1 |
| 16 | 251 | |
| 17 | 309 | |
| 18 | 28 | |
| 19 | 101 | |
| 20 | 66 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.